Obviously Sacklers do not want our (or any) generic oxy to hit the market. But I don’t understand what keeping our share price from its true value benefits them when it comes to a generic oxy approval
Yeah, they would have the most game possibly like the idiots. They are thinking they can drive it down and buy it out but and then probably loading up shares themselves but just making trouble since we’re trying to move in on their market. Oh well destiny is our destiny. They can’t stop it.
Market Data 
Markets 
AI
